Toll Free: 1-888-928-9744
Published: Dec, 2016 | Pages:
49 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Hutchison MediPharma Ltd - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Hutchison MediPharma Ltd - Product Pipeline Review - 2016', provides an overview of the Hutchison MediPharma Ltd's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Hutchison MediPharma Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Hutchison MediPharma Ltd - The report provides overview of Hutchison MediPharma Ltd including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Hutchison MediPharma Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Hutchison MediPharma Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Hutchison MediPharma Ltd's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Hutchison MediPharma Ltd - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Hutchison MediPharma Ltd's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Hutchison MediPharma Ltd Snapshot 6 Hutchison MediPharma Ltd Overview 6 Key Facts 6 Hutchison MediPharma Ltd - Research and Development Overview 7 Key Therapeutic Areas 7 Hutchison MediPharma Ltd - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Hutchison MediPharma Ltd - Pipeline Products Glance 12 Hutchison MediPharma Ltd - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Hutchison MediPharma Ltd - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Hutchison MediPharma Ltd - Early Stage Pipeline Products 15 IND/CTA Filed Products/Combination Treatment Modalities 15 Preclinical Products/Combination Treatment Modalities 16 Hutchison MediPharma Ltd - Drug Profiles 17 HMPL-012 - Drug Profile 17 Product Description 17 Mechanism Of Action 17 R&D Progress 17 HMPL-013 - Drug Profile 21 Product Description 21 Mechanism Of Action 21 R&D Progress 21 HMPL-309 - Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 HMPL-453 - Drug Profile 27 Product Description 27 Mechanism Of Action 27 R&D Progress 27 HMPL-507 - Drug Profile 28 Product Description 28 Mechanism Of Action 28 R&D Progress 28 HMPL-518 - Drug Profile 29 Product Description 29 Mechanism Of Action 29 R&D Progress 29 HMPL-523 - Drug Profile 30 Product Description 30 Mechanism Of Action 30 R&D Progress 30 HMPL-689 - Drug Profile 32 Product Description 32 Mechanism Of Action 32 R&D Progress 32 HMPL-813 - Drug Profile 33 Product Description 33 Mechanism Of Action 33 R&D Progress 33 savolitinib - Drug Profile 35 Product Description 35 Mechanism Of Action 35 R&D Progress 35 Hutchison MediPharma Ltd - Pipeline Analysis 40 Hutchison MediPharma Ltd - Pipeline Products by Target 40 Hutchison MediPharma Ltd - Pipeline Products by Route of Administration 42 Hutchison MediPharma Ltd - Pipeline Products by Molecule Type 43 Hutchison MediPharma Ltd - Pipeline Products by Mechanism of Action 44 Hutchison MediPharma Ltd - Dormant Projects 46 Hutchison MediPharma Ltd - Locations And Subsidiaries 47 Head Office 47 Other Locations & Subsidiaries 47 Appendix 48 Methodology 48 Coverage 48 Secondary Research 48 Primary Research 48 Expert Panel Validation 48 Contact Us 48 Disclaimer 49
List of Tables
Hutchison MediPharma Ltd, Key Facts 6 Hutchison MediPharma Ltd - Pipeline by Indication, 2016 8 Hutchison MediPharma Ltd - Pipeline by Stage of Development, 2016 10 Hutchison MediPharma Ltd - Monotherapy Products in Pipeline, 2016 11 Hutchison MediPharma Ltd - Phase III, 2016 12 Hutchison MediPharma Ltd - Phase II, 2016 13 Hutchison MediPharma Ltd - Phase I, 2016 14 Hutchison MediPharma Ltd - IND/CTA Filed, 2016 15 Hutchison MediPharma Ltd - Preclinical, 2016 16 Hutchison MediPharma Ltd - Pipeline by Target, 2016 41 Hutchison MediPharma Ltd - Pipeline by Route of Administration, 2016 42 Hutchison MediPharma Ltd - Pipeline by Molecule Type, 2016 43 Hutchison MediPharma Ltd - Pipeline Products by Mechanism of Action, 2016 45 Hutchison MediPharma Ltd - Dormant Developmental Projects,2016 46 Hutchison MediPharma Ltd, Other Locations 47
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.